by Stephen Manobiano | Feb 13, 2026 | Commercialization, news, tradeshows
SLAS Boston is expensive. Booth space. Freight. Travel. Hotels. Sponsorships. Swag.For many life science companies, the total investment quietly creeps into six figures. The real question executives should be asking right now isn’t: “How was the show?” It’s: Did it...
by Stephen Manobiano | Jan 15, 2026 | Insight, Marketing
Most nurture campaigns fail for one simple reason: they push products before earning trust. In life sciences, buying decisions are slow, technical, and rarely made by a single person. Whether you’re selling reagents, CRO services, capital equipment, or platforms, your...
by Stephen Manobiano | Dec 17, 2025 | brand awareness, event, Insight, Sales, tradeshows
Life science conferences, whether ADLM, ASHG, BIO, PEGS, or a niche scientific meeting, are expensive in both time and money. Registration fees, travel, and days away from the lab or office add up quickly. Yet most attendees still approach these events passively:...
by Stephen Manobiano | Dec 12, 2025 | Insight, Marketing, omnichannel
Life science researchers are some of the most sophisticated and overloaded readers in any industry. They receive countless emails from reagent suppliers, CROs, CDMOs, publication platforms, equipment vendors, software tools, and conference organizers. To earn...
by Stephen Manobiano | Nov 18, 2025 | business development, Fractional, Insight, Marketing, Sales
Marketing, Business Development, and Sales Acceleration, Without Fixed Overhead. In today’s biotech and life science markets, capital efficiency is necessary.Funding cycles are longer, sales cycles are slower, and investors demand traction before term sheets. Yet the...
